By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Viennese start-up carries out research on drug to fight tuberculosis

"We are beginning with tuberculosis", the CEO added. The California-based biotech company Trianni Inc. which Wabl established a few years ago has ensured the necessary pre-requisites for this. “The main problem is the resistance against antibiotics, but there is an alternative, namely antibodies”, said the trained chemist and biologist, who teaches microbiology and immunology at the American university. Trianni created the platform enabling the antibodies to be identified. This means genetic mice developed for this purpose. In addition to various pharmaceutical companies, Austrianni is one of the licensees of the patented antibody platform and can continue researching on this basis. The mice mentioned above produce the humanized antibodies needed to fight tuberculosis and other diseases.

The business location decision of Austrianni was not only based on the roots of the company’s founder in Austria. „There are very generous funding possibilities here. This is one of the main reasons“, Wabl added. Up to 70 percent of the project costs can be contributed by the Austrian Research Promotion Agency FFG. Moreover, Austria “is making great efforts to expand its biotech sector”, Wabl concluded.

 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • China International Fair for Investment & Trade

    08.09. - 11.09. 2020, Xiamen, China

  • Finanzgipfel 2020

    17.09.2020/ 08:00 , Frankfurt, Deutschland

Austria Map

Find the perfect location for your company

The openness towards innovations, that one can find everywhere within Austria was our basis to bring FAIRTIQ to Austria first, after Switzerland and Liechtenstein. FAIRTIQ is looking forward to accompany our existing and also our new partners in Austria on all their upcoming and successful journeys.

FAIRTIQ

Logo: FAIRTIQ
More testimonials

news from the business location Austria

Novartis extends penicillin production in Tyrol

The Swiss pharmaceutical company Novartis decides on location Austria and invests 2.5 Billion EURO into penicillin production.

“Cash or card?” - Austria, the coronavirus pandemic and the increasing trend towards cashless payment.

The number of cashless transactions in Austria has been increasing for years. This upward trend once again experienced a tremendous boost due to the coronavirus pandemic.

More news All blog posts